Down-regulation of pancreatic growth and gallbladder contractility by bile salts
- PMID: 2910123
- DOI: 10.1016/0002-9610(89)90414-5
Down-regulation of pancreatic growth and gallbladder contractility by bile salts
Abstract
Luminal sequestration of bile salts with cholestyramine and the oral administration of bile salts represent current forms of therapy for some diseases. We have recently reported that secretion of these salts exerts negative feedback control on the release of cholecystokinin (CCK). The purpose of this study was to examine the effects of long-term alterations of luminal concentrations of bile salts on CCK target organs, the pancreas and gallbladder. The bile salt pool in adult guinea pigs was either enriched by feeding 0.5 percent sodium taurocholate or depleted by feeding 2 percent cholestyramine. Pancreatic growth, gallbladder contractility, the concentration of cholecystokinin receptors in the gallbladder muscle, and meal-stimulated plasma levels of cholecystokinin were significantly stimulated by feeding the bile salt sequestrant cholestyramine to guinea pigs. Administration of the bile salt taurocholate produced the opposite effects. Inhibition of CCK release by bile salts and up-regulation of CCK receptors by CCK may be the mechanisms responsible for the actions of bile salts on CCK target organs.
Similar articles
-
Endogenous cholecystokinin regulates growth of human cholangiocarcinoma.Ann Surg. 1989 Sep;210(3):317-22; discussion 322-3. doi: 10.1097/00000658-198909000-00007. Ann Surg. 1989. PMID: 2476084 Free PMC article.
-
Reduced cholecystokinin mediates the inhibition of pancreatic growth induced by bile salts.Am J Physiol. 1990 Jul;259(1 Pt 1):G86-92. doi: 10.1152/ajpgi.1990.259.1.G86. Am J Physiol. 1990. PMID: 1695489
-
Chronic effect of oral cholestyramine, a bile salt sequestrant, and exogenous cholecystokinin on insulin release in rats.Pancreas. 1992;7(1):15-20. doi: 10.1097/00006676-199201000-00003. Pancreas. 1992. PMID: 1557341
-
Role of bile acids in the control of pancreatic secretion and CCK release.Eur J Clin Invest. 1990 Oct;20 Suppl 1:S51-7. doi: 10.1111/j.1365-2362.1990.tb01778.x. Eur J Clin Invest. 1990. PMID: 2124998 Review.
-
Feedback inhibition of cholecystokinin secretion by bile acids and pancreatic proteases.Ann N Y Acad Sci. 1994 Mar 23;713:167-79. doi: 10.1111/j.1749-6632.1994.tb44064.x. Ann N Y Acad Sci. 1994. PMID: 8185158 Review.
Cited by
-
Protective action of luminal bile salts in necrotizing acute pancreatitis in mice.J Clin Invest. 1990 Jul;86(1):323-31. doi: 10.1172/JCI114703. J Clin Invest. 1990. PMID: 1694866 Free PMC article.
-
Endogenous cholecystokinin regulates growth of human cholangiocarcinoma.Ann Surg. 1989 Sep;210(3):317-22; discussion 322-3. doi: 10.1097/00000658-198909000-00007. Ann Surg. 1989. PMID: 2476084 Free PMC article.
-
Gallbladder motility, gallstones, and the surgeon.Dig Dis Sci. 1995 Nov;40(11):2323-35. doi: 10.1007/BF02063233. Dig Dis Sci. 1995. PMID: 7587810 Review.
-
Mechanisms of cisapride affecting gallbladder motility.Dig Dis Sci. 2001 May;46(5):939-44. doi: 10.1023/a:1010722905406. Dig Dis Sci. 2001. PMID: 11341662 Review.
-
Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones.Dig Dis Sci. 1999 Jan;44(1):190-6. doi: 10.1023/a:1026635124115. Dig Dis Sci. 1999. PMID: 9952243
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources